News

27/08/14
Stallergenes to be present at the Morgan Stanley Global Healthcare Conference on September 10, 2014

STALLERGENES S.A. (Euronext Paris), a global healthcare company...

[more]
24/07/14
Half-year revenues and results

Increase in revenues in line with full-year targets (+1.2%)

Very strong...

[more]

Follow us on :

STALLERGENES, A GLOBAL ALLERGY PLAYER


Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. 

Stallergenes has a comprehensive approach of the allergic diseases with a complete portfolio combining diagnosis products and treatments and has brought the new generation of allergen immunotherapy treatments.